J
Janux Therapeutics D
D
JANX
26.380
USD
-0.15
(-0.57%)
مغلق
حجم التداول
42,917
الربح لكل سهم
-2
العائد الربحي
-
P/E
-15
حجم السوق
1,585,277,926
العنوان: Janux Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T CellEngagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with atumor antigen-binding domain and a costimulatory CD28 binding domain.